Comgest Global Investors S.a.s. Lowers stake in Cavium Inc (CAVM)

Cavium Inc (CAVM) : Comgest Global Investors S.a.s. reduced its stake in Cavium Inc by 2.05% during the most recent quarter end. The investment management company now holds a total of 372,017 shares of Cavium Inc which is valued at $17.2 Million after selling 7,786 shares in Cavium Inc , the firm said in a disclosure report filed with the SEC on May 12, 2016.Cavium Inc makes up approximately 0.59% of Comgest Global Investors S.a.s.’s portfolio.

Other Hedge Funds, Including , Canada Pension Plan Investment Board sold out all of its stake in CAVM during the most recent quarter. The investment firm sold 4,400 shares of CAVM which is valued $202,884.New York State Common Retirement Fund boosted its stake in CAVM in the latest quarter, The investment management firm added 29,927 additional shares and now holds a total of 180,404 shares of Cavium Inc which is valued at $8.5 Million. Cavium Inc makes up approx 0.01% of New York State Common Retirement Fund’s portfolio.Bronfman E.l. Rothschild reduced its stake in CAVM by selling 55 shares or 21.57% in the most recent quarter. The Hedge Fund company now holds 200 shares of CAVM which is valued at $9,412.Schwab Charles Investment Management Inc boosted its stake in CAVM in the latest quarter, The investment management firm added 8,593 additional shares and now holds a total of 212,041 shares of Cavium Inc which is valued at $10 Million. Cavium Inc makes up approx 0.01% of Schwab Charles Investment Management Inc’s portfolio.

Cavium Inc opened for trading at $46.38 and hit $47.73 on the upside on Friday, eventually ending the session at $47.2, with a gain of 2.59% or 1.19 points. The heightened volatility saw the trading volume jump to 7,61,958 shares. Company has a market cap of $2,706,212 M.

On the company’s financial health, Cavium Inc reported $0.25 EPS for the quarter, based on the information available during the earnings call on Apr 27, 2016. Analyst had a consensus estimate of $0.25. The company had revenue of $101.90 million for the quarter, compared to analysts expectations of $102.01 million. The company’s revenue was up .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS.

Many Wall Street Analysts have commented on Cavium Inc. Shares were Reiterated by Barclays on May 13, 2016 to “Overweight” and Lowered the Price Target to $ 65 from a previous price target of $75 .Brean Capital Initiated Cavium Inc on May 3, 2016 to “Buy”, Price Target of the shares are set at $67.Shares were Reiterated by Topeka Capital Markets on Apr 28, 2016 to “Hold” and Lowered the Price Target to $ 55 from a previous price target of $63 .

Cavium Inc. is a provider of semiconductor processors which enable processing for wired and wireless networking communications storage cloud wireless security video and connected home and office applications. The Company’s products include OCTEON OCTEON Plus OCTEON Fusion OCTEON XL LiquidIO NITROX NEURON Search and PureVu. The Company’s OCTEON OCTEON Plus OCTEON II and OCTEON III Multi-core MIPS64 processor families provide data and security processing. The LiquidIO Server Adapter family is a server compliant half-height Peripheral Component Interconnect Express (PCI Express). The NITROX processor family offers security processors. The NEURON Search processor family targets a range of Layer 2 to Layer 4 network search applications in enterprise and service provider infrastructure equipment. The PureVu product family is an integrated media system on a chip (SoC). The Company also offers ThunderX a multi-core SoC processor and MontaVista software products.

Leave a Reply

Cavium Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cavium Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.